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The Effects of Ligands / Activaters of the Peroxisome Proliferated-Activated Receptor (PPAR) on the 
Expression of the Superoxide Scavenger Enzyme, Cu2+, Zn2+-Superoxide Dismutase (CuZn-SOD), Mn2+-
Superoxide Dismutase (Mn-SOD), and the Superoxide Generating Enzyme Nicotinamide Adenine 
Dinucleotide Phosphate (NADPH) Oxidase in Primary Cultures of Human Umbilical Vein Endothelial 
Cells (HUVEC)
Seiichi Gotoh, Ikuo Inoue, Kenji Hayashi (Fourth Department of Medicine, Saitama Medical School, Moroyama, 
Iruma-gun, Saitama 350-0495, Japan)
We examined the effects of ligands / activators of the peroxisome proliferated-activated receptor (PPAR) on the 
expression of the superoxide scavenger enzyme, Cu2+, Zn2+-superoxide dismutase (CuZn-SOD), Mn2+-superoxide 
dismutase (Mn-SOD), and the superoxide generating enzyme nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidase in primary cultures of human umbilical vein endothelial cells (HUVEC). Bezafibrate, 
which is a ligand / activator for PPARα , increased the CuZn-SOD, Mn-SOD, and catalase gene and protein 
expression levels in endothelial cells. In addition, the levels of mRNA and protein for phorbol myristate acetate 
(PMA)-stimulated 22-kDaα -subunit (p22phox), 47-kDaα -subunit (p47phox) and 67-kDa α -subunit in NADPH 
oxidase were decreased by treatment with PPARα ligands / activators. These results suggest that PPARα gene 
and protein expression in endothelial cells may play a physiological role as not only lipid metabolism but also 
active oxygen turnover and / or their elimination system, although the details of these mechanisms is now in 
progress.
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Gene Co. Ltd., Toyama, Japan）を用いて，HUVEC （107
細胞）から分離した全RNAを，オリゴ（dT）プライマー













































自動塩基配列決定装置（ABI PRISM 310 Genetic 









































のKpn I/Nco I （pGL3-Basic）（Promega, WI, USA）に挿











した．3 μgのPPARαをTfxTM-50Reagent （Promega, 



































Fig. 1. The appearance of PPARα, PPARβ/δ/Nuc1, PPARγ with 10% FBS by RT-PCR in HUVEC. Gene appearance of PPAR
α was 1/2 of those of PPARβ/δ/Nuc1, and was 2 times of those of PPARγ. Data indicate the mean±SD, ＊p＜0.05 vs PPARα.
Fig. 2.  Change of PPARα mRNA of HUVEC by bezafi brate. 
Bezafi brate signifi cantly increased the PPAR α gene expres-
sion. Data indicate the mean±SD, ＊p＜ 0.05 vs control.
Fig. 3. Time-dependent ef fect of bezafi brate on protein 
appearance of PPARα in HUVEC. The change of PPARα
protein levels by bezafi brate was maximum in 12hours.
Fig. 4. Dose-dependent ef fect of bezafi brate on protein 
appearance of PPARα in HUVEC. The change of PPARα
protein levels by bezafi brate was maximum at 2 μM.
Fig. 5. Transcription activity of PPARα/RXRα  by 
bezafi brate. The transcription activity of PPARα/RXRα was 
signifi cantly increased by bezafi brate. Data indicate the mean
±SD, ＊p＜0.05 .
Fig. 6. The effect of bezafi brate on CuZn-SOD mRNA and protein levels. Bezafi brate signifi cantly increased the CuZn-SOD 
mRNA and protein levels in HUVEC. Data indicate the mean±SD, ＊p＜0.05 vs control.
31PPARαの培養内皮細胞における Cu2+Zn2+-SOD， Mn2+-SOD，NADPHオキシダーゼへの作用
ホルボール（PMA）を添加したところ，NADPHオ
キシダーゼの22- kDa α -サブユニット（p22phox），




































Fig. 7. The effect of bezafi brate on p22phox, p47phox, p67phox mRNA levels. Bezafi brate signifi cantly attenuated the mRNA 
levels, which were induced by PMA.  Data indicate the mean±SD, ＊p＜0.05 vs control, ＊＊p＜0.05 vs PMA.
Fig. 8. The effect of bezafi brate on CuZn-SOD, Mn-SOD, catalase, p22phox, p47phox, p67phox protein levels. Bezafi brate 
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